Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1167

1.

A Case of Atrophic Dermatofibroma Overexpressing Matrix Metalloproteinase-1.

Yano-Takamori A, Tsuji G, Nakahara T, Kido-Nakahara M, Furue M.

Case Rep Dermatol. 2019 Oct 1;11(3):264-267. doi: 10.1159/000503136. eCollection 2019 Sep-Dec.

2.

Clinical practice guidelines for the management of atopic dermatitis 2018.

Katoh N, Ohya Y, Ikeda M, Ebihara T, Katayama I, Saeki H, Shimojo N, Tanaka A, Nakahara T, Nagao M, Hide M, Fujita Y, Fujisawa T, Futamura M, Masuda K, Murota H, Yamamoto-Hanada K.

J Dermatol. 2019 Oct 9. doi: 10.1111/1346-8138.15090. [Epub ahead of print]

PMID:
31599013
3.

Impact of type of emergency department on the outcome of out-of-hospital cardiac arrest: a prospective cohort study.

Kaneda K, Yagi T, Todani M, Nakahara T, Fujita M, Kawamura Y, Oda Y, Tsuruta R.

Acute Med Surg. 2019 May 22;6(4):371-378. doi: 10.1002/ams2.423. eCollection 2019 Oct.

4.

Ribavirin induces hepatitis C virus genome mutations in chronic hepatitis patients who failed to respond to prior daclatasvir plus asunaprevir therapy.

Saito Y, Imamura M, Uchida T, Osawa M, Teraoka Y, Fujino H, Nakahara T, Ono A, Murakami E, Kawaoka T, Miki D, Tsuge M, Serikawa M, Aikata H, Abe-Chayama H, Hayes CN, Chayama K.

J Med Virol. 2019 Oct 4. doi: 10.1002/jmv.25602. [Epub ahead of print]

PMID:
31584207
5.

Consensus statements on pediatric atopic dermatitis from dermatology and pediatrics practitioners in Japan: Goals of treatment and topical therapy.

Arakawa H, Shimojo N, Katoh N, Hiraba K, Kawada Y, Yamanaka K, Igawa K, Murota H, Okafuji I, Fukuie T, Nakahara T, Noguchi T, Kanakubo A, Katayama I.

Allergol Int. 2019 Sep 23. pii: S1323-8930(19)30135-2. doi: 10.1016/j.alit.2019.08.006. [Epub ahead of print]

6.

Cellular Mechanisms of Angiogenesis in Neonatal Rat Models of Retinal Neurodegeneration.

Asano D, Hokazono M, Hirano S, Morita A, Nakahara T.

Int J Mol Sci. 2019 Sep 25;20(19). pii: E4759. doi: 10.3390/ijms20194759.

7.

The IL-13-OVOL1-FLG axis in atopic dermatitis.

Furue K, Ito T, Tsuji G, Ulzii D, Vu YH, Kido-Nakahara M, Nakahara T, Furue M.

Immunology. 2019 Sep 11. doi: 10.1111/imm.13120. [Epub ahead of print] Review.

PMID:
31509236
8.

Development of Upright Computed Tomography With Area Detector for Whole-Body Scans: Phantom Study, Efficacy on Workflow, Effect of Gravity on Human Body, and Potential Clinical Impact.

Jinzaki M, Yamada Y, Nagura T, Nakahara T, Yokoyama Y, Narita K, Ogihara N, Yamada M.

Invest Radiol. 2019 Sep 9. doi: 10.1097/RLI.0000000000000603. [Epub ahead of print]

PMID:
31503082
9.

Management of refractory ascites attenuates muscle mass reduction and improves survival in patients with decompensated cirrhosis.

Namba M, Hiramatsu A, Aikata H, Kodama K, Uchikawa S, Ohya K, Morio K, Fujino H, Nakahara T, Murakami E, Yamauchi M, Kawaoka T, Tsuge M, Imamura M, Chayama K.

J Gastroenterol. 2019 Sep 4. doi: 10.1007/s00535-019-01623-4. [Epub ahead of print]

PMID:
31485782
10.

Impact of the cerebrospinal fluid-mask algorithm on the diagnostic performance of 123I-Ioflupane SPECT: an investigation of parkinsonian syndromes.

Iwabuchi Y, Nakahara T, Kameyama M, Matsusaka Y, Minami Y, Ito D, Tabuchi H, Yamada Y, Jinzaki M.

EJNMMI Res. 2019 Sep 3;9(1):85. doi: 10.1186/s13550-019-0558-x.

11.

Successful retreatment with 12 weeks of glecaprevir and pibrentasvir for a genotype 2a HCV-infected hemodialysis patient who failed to respond to 8 weeks of prior glecaprevir and pibrentasvir therapy.

Ohya K, Imamura M, Osawa M, Teraoka Y, Morio K, Fujino H, Ono A, Nakahara T, Murakami E, Yamauchi M, Kawaoka T, Hiramatsu A, Tsuge M, Aikata H, Hayes CN, Chayama K.

Clin J Gastroenterol. 2019 Aug 28. doi: 10.1007/s12328-019-01039-w. [Epub ahead of print]

PMID:
31463795
12.

Abnormal Uptake and Air Trapping in Hypersensitivity Pneumonitis Detected on FDG PET/CT.

Matsusaka Y, Kawada I, Nakahara T, Iwabuchi Y, Kawaida M, Matsusaka M, Jinzaki M.

Am J Respir Crit Care Med. 2019 Aug 28. doi: 10.1164/rccm.201903-0626IM. [Epub ahead of print] No abstract available.

PMID:
31461629
13.

Hemodynamic stress distribution identified by SPECT reflects ischemic symptoms of Moyamoya disease patients.

Arai N, Horiguchi T, Takahashi S, Nakahara T, Akiyama T, Jinzaki M, Yoshida K.

Neurosurg Rev. 2019 Aug 23. doi: 10.1007/s10143-019-01145-w. [Epub ahead of print]

PMID:
31444715
14.

IL-4 Augments IL-31/IL-31 Receptor Alpha Interaction Leading to Enhanced Ccl 17 and Ccl 22 Production in Dendritic Cells: Implications for Atopic Dermatitis.

Miake S, Tsuji G, Takemura M, Hashimoto-Hachiya A, Vu YH, Furue M, Nakahara T.

Int J Mol Sci. 2019 Aug 20;20(16). pii: E4053. doi: 10.3390/ijms20164053.

15.

Early changes in ammonia levels and liver function in patients with advanced hepatocellular carcinoma treated by lenvatinib therapy.

Ohya K, Kawaoka T, Namba M, Uchikawa S, Kodama K, Morio K, Nakahara T, Murakami E, Hiramatsu A, Tsuge M, Yamauchi M, Imamura M, Chayama K, Aikata H.

Sci Rep. 2019 Aug 20;9(1):12101. doi: 10.1038/s41598-019-48045-z.

16.

Upregulation of IL-36 cytokines in folliculitis and eosinophilic pustular folliculitis.

Sato S, Chiba T, Nakahara T, Furue M.

Australas J Dermatol. 2019 Aug 19. doi: 10.1111/ajd.13143. [Epub ahead of print]

PMID:
31424098
17.

Activation of transient receptor potential vanilloid 4 channels dilates rat retinal arterioles through nitric oxide- and BKCa channel-dependent mechanisms in vivo.

Mori A, Takeda K, Sakamoto K, Nakahara T.

Naunyn Schmiedebergs Arch Pharmacol. 2019 Aug 8. doi: 10.1007/s00210-019-01707-1. [Epub ahead of print]

PMID:
31392384
18.

Severe Fever with Thrombocytopenia Syndrome Complicated with Pseudomembranous Aspergillus Tracheobronchitis in a Patient without Apparent Risk Factors for Invasive Aspergillosis: A Case Report.

Sakaguchi K, Koga Y, Yagi T, Nakahara T, Todani M, Fujita M, Tsuruta R.

Intern Med. 2019 Jul 31. doi: 10.2169/internalmedicine.3257-19. [Epub ahead of print]

19.

Vascular Calcification: The Evolving Relationship of Vascular Calcification to Major Acute Coronary Events.

Strauss HW, Nakahara T, Narula N, Narula J.

J Nucl Med. 2019 Sep;60(9):1207-1212. doi: 10.2967/jnumed.119.230276. Epub 2019 Jul 26. Review.

PMID:
31350320
20.

Uncovering the mouse olfactory long non-coding transcriptome with a novel machine-learning model.

Camargo AP, Nakahara TS, Firmino LER, Netto PHM, do Nascimento JBP, Donnard ER, Galante PAF, Carazzolle MF, Malnic B, Papes F.

DNA Res. 2019 Aug 1;26(4):365-378. doi: 10.1093/dnares/dsz015.

21.

Attenuation of Retinal Endothelial Vasodilator Function in a Rat Model of Retinopathy of Prematurity.

Nakano A, Mori A, Arima S, Asano D, Morita A, Sakamoto K, Nagamitsu T, Nakahara T.

Curr Eye Res. 2019 Jul 18:1-9. doi: 10.1080/02713683.2019.1641825. [Epub ahead of print]

PMID:
31317786
22.

Does mechanical scratching cause the recruitment of T-helper 17 cells in atopic dermatitis?

Furue K, Ito T, Tsuji G, Esaki H, Kido-Nakahara M, Nakahara T, Furue M.

J Dermatol. 2019 Jul 11. doi: 10.1111/1346-8138.15011. [Epub ahead of print] No abstract available.

PMID:
31294475
23.

Response to: Effects of breathing motion on PET acquisitions: step and shoot versus continuous bed motion.

Owaki Y, Nakahara T, Shimizu T, Smith AM, Luk WK, Inoue K, Fukushi M, Nakajima K.

Nucl Med Commun. 2019 Aug;40(8):873-874. doi: 10.1097/MNM.0000000000001045. No abstract available.

PMID:
31290851
24.

Three-dimensional radiologic-pathologic correlation of medication-related osteonecrosis of the jaw using 3D bone SPECT/CT imaging.

Miyashita H, Kameyama K, Morita M, Nakagawa T, Nakahara T.

Dentomaxillofac Radiol. 2019 Jul 11:20190208. doi: 10.1259/dmfr.20190208. [Epub ahead of print]

PMID:
31287720
25.

Scratching Counteracts IL-13 Signaling by Upregulating the Decoy Receptor IL-13Rα2 in Keratinocytes.

Ulzii D, Kido-Nakahara M, Nakahara T, Tsuji G, Furue K, Hashimoto-Hachiya A, Furue M.

Int J Mol Sci. 2019 Jul 6;20(13). pii: E3324. doi: 10.3390/ijms20133324.

26.

An Ex-Vivo Culture System of Ovarian Cancer Faithfully Recapitulating the Pathological Features of Primary Tumors.

Ghani FI, Dendo K, Watanabe R, Yamada K, Yoshimatsu Y, Yugawa T, Nakahara T, Tanaka K, Yoshida H, Yoshida M, Ishikawa M, Goshima N, Kato T, Kiyono T.

Cells. 2019 Jun 26;8(7). pii: E644. doi: 10.3390/cells8070644.

27.

Correlation between Early Tumor Marker Response and Imaging Response in Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib.

Kodama K, Kawaoka T, Namba M, Uchikawa S, Ohya K, Morio K, Nakahara T, Murakami E, Yamauchi M, Hiramatsu A, Imamura M, Chayama K, Aikata H.

Oncology. 2019;97(2):75-81. doi: 10.1159/000499715. Epub 2019 Jun 26.

PMID:
31242488
28.

Efficacy of glecaprevir and pibrentasvir treatment for genotype 1b hepatitis C virus drug resistance-associated variants in humanized mice.

Osawa M, Uchida T, Imamura M, Teraoka Y, Fujino H, Nakahara T, Ono A, Murakami E, Kawaoka T, Miki D, Tsuge M, Hiramatsu A, Abe-Chayama H, Hayes CN, Makokha GN, Aikata H, Ishida Y, Tateno C, Miyayama Y, Hijikata M, Chayama K.

J Gen Virol. 2019 Jul;100(7):1123-1131. doi: 10.1099/jgv.0.001268. Epub 2019 Jun 14.

PMID:
31199224
29.

Pathogenesis of Atopic Dermatitis: Current Paradigm.

Furue M, Ulzii D, Vu YH, Tsuji G, Kido-Nakahara M, Nakahara T.

Iran J Immunol. 2019 Jun;16(2):97-107. doi: 10.22034/IJI.2019.80253.

30.

Binimetinib, a novel MEK1/2 inhibitor, exerts anti-leukemic effects under inactive status of PI3Kinase/Akt pathway.

Sakakibara K, Tsujioka T, Kida JI, Kurozumi N, Nakahara T, Suemori SI, Kitanaka A, Arao Y, Tohyama K.

Int J Hematol. 2019 Aug;110(2):213-227. doi: 10.1007/s12185-019-02667-1. Epub 2019 May 25.

PMID:
31129802
31.

Roles for E1-independent replication and E6-mediated p53 degradation during low-risk and high-risk human papillomavirus genome maintenance.

Murakami I, Egawa N, Griffin H, Yin W, Kranjec C, Nakahara T, Kiyono T, Doorbar J.

PLoS Pathog. 2019 May 13;15(5):e1007755. doi: 10.1371/journal.ppat.1007755. eCollection 2019 May.

32.

Role of Neuron⁻Glia Signaling in Regulation of Retinal Vascular Tone in Rats.

Someya E, Akagawa M, Mori A, Morita A, Yui N, Asano D, Sakamoto K, Nakahara T.

Int J Mol Sci. 2019 Apr 20;20(8). pii: E1952. doi: 10.3390/ijms20081952.

33.

Simple patient-specific instrument for intraoral vertical ramus osteotomy.

Ohtani T, Habu M, Nakahara T, Tominaga K, Yoshioka I.

Br J Oral Maxillofac Surg. 2019 May;57(4):381-382. doi: 10.1016/j.bjoms.2019.03.010. Epub 2019 Apr 6. No abstract available.

PMID:
30967295
34.

Clinical value of 3D SPECT/CT imaging for assessing jaw bone invasion in oral cancer patients.

Miyashita H, Nakahara T, Asoda S, Kameyama K, Kawaida M, Enomoto R, Shiba H, Jinzaki M, Kawana H, Nakagawa T.

J Craniomaxillofac Surg. 2019 Jul;47(7):1139-1146. doi: 10.1016/j.jcms.2019.03.013. Epub 2019 Mar 18.

PMID:
30952473
35.

IgG4-related periarteritis of the carotid artery.

Matsusaka Y, Kikuchi T, Nakahara T, Iwabuchi Y, Jinzaki M.

QJM. 2019 Oct 1;112(10):805-806. doi: 10.1093/qjmed/hcz068. No abstract available.

PMID:
30895311
36.

Bone SPECT-based segmented attenuation correction for quantitative analysis of bone metastasis (B-SAC): comparison with CT-based attenuation correction.

Nakahara T, Owaki Y, Shindou T, Nakajima K, Jinzaki M.

EJNMMI Res. 2019 Mar 19;9(1):27. doi: 10.1186/s13550-019-0501-1.

37.

Involvement of matrix metalloproteinases in capillary degeneration following NMDA-induced neurotoxicity in the neonatal rat retina.

Asano D, Morita A, Mori A, Sakamoto K, Ishii K, Nakahara T.

Exp Eye Res. 2019 May;182:101-108. doi: 10.1016/j.exer.2019.03.005. Epub 2019 Mar 16.

PMID:
30885712
38.

Most Important Prognostic Values to Predict Major Adverse Cardiovascular, Cerebrovascular, and Renal Events in Patients with Chronic Kidney Disease Including Hemodialysis for 2 Years.

Toyama T, Kasama S, Sato M, Sano H, Ueda T, Sasaki T, Nakahara T, Higuchi T, Tsushima Y, Kurabayashi M.

Cardiology. 2019;142(1):14-23. doi: 10.1159/000496330. Epub 2019 Mar 13.

PMID:
30865950
39.

Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis.

Hiramatsu A, Aikata H, Uchikawa S, Ohya K, Kodama K, Nishida Y, Daijo K, Osawa M, Teraoka Y, Honda F, Inagaki Y, Morio K, Morio R, Fujino H, Nakahara T, Murakami E, Yamauchi M, Kawaoka T, Miki D, Tsuge M, Imamura M, Tanaka J, Chayama K.

Hepatol Commun. 2019 Jan 22;3(3):348-355. doi: 10.1002/hep4.1309. eCollection 2019 Mar.

40.

18F-Fluoride Positron Emission Tomographic Imaging of Penile Arteries and Erectile Dysfunction.

Nakahara T, Narula J, Tijssen JGP, Agarwal S, Chowdhury MM, Coughlin PA, Dweck MR, Rudd JHF, Jinzaki M, Mulhall J, Strauss HW.

J Am Coll Cardiol. 2019 Apr 2;73(12):1386-1394. doi: 10.1016/j.jacc.2018.10.076. Epub 2019 Mar 4.

PMID:
30846336
41.

Comparison of intracellular responses between HBV genotype A and C infection in human hepatocyte chimeric mice.

Tsushima K, Tsuge M, Hiraga N, Uchida T, Murakami E, Makokha GN, Kurihara M, Nomura M, Hiyama Y, Fujino H, Ono A, Nakahara T, Yamauchi M, Abe-Chayama H, Kawaoka T, Miki D, Imamura M, Aikata H, Hayes CN, Chayama K.

J Gastroenterol. 2019 Jul;54(7):650-659. doi: 10.1007/s00535-019-01558-w. Epub 2019 Feb 21.

PMID:
30790056
42.

Activator of G-protein signaling 8 is involved in VEGF-induced choroidal neovascularization.

Hayashi H, Mamun AA, Takeyama M, Yamamura A, Zako M, Yagasaki R, Nakahara T, Kamei M, Sato M.

Sci Rep. 2019 Feb 7;9(1):1560. doi: 10.1038/s41598-018-38067-4.

43.

Probucol Slows the Progression of Cataracts in Streptozotocin-Induced Hyperglycemic Rats.

Higashi K, Mori A, Sakamoto K, Ishii K, Nakahara T.

Pharmacology. 2019;103(3-4):212-219. doi: 10.1159/000496055. Epub 2019 Feb 5.

PMID:
30721902
44.

Percutaneous transvenous shunt occlusion for portosystemic encephalopathy due to lenvatinib administration to a patient with hepatocellular carcinoma and portosystemic shunt.

Namba M, Kawaoka T, Aikata H, Kodama K, Uchikawa S, Ohya K, Morio K, Fujino H, Nakahara T, Murakami E, Yamauchi M, Tsuge M, Hiramatsu A, Imamura M, Baba Y, Awai K, Chayama K.

Clin J Gastroenterol. 2019 Aug;12(4):341-346. doi: 10.1007/s12328-019-00938-2. Epub 2019 Jan 31.

PMID:
30706429
45.

Impact of a combination of quantitative indices representing uptake intensity, shape, and asymmetry in DAT SPECT using machine learning: comparison of different volume of interest settings.

Iwabuchi Y, Nakahara T, Kameyama M, Yamada Y, Hashimoto M, Matsusaka Y, Osada T, Ito D, Tabuchi H, Jinzaki M.

EJNMMI Res. 2019 Jan 28;9(1):7. doi: 10.1186/s13550-019-0477-x.

PMID:
30689072
46.

Can we predict amyloid deposition by objective cognition and regional cerebral blood flow in patients with subjective cognitive decline?

Funaki K, Nakajima S, Noda Y, Wake T, Ito D, Yamagata B, Yoshizaki T, Kameyama M, Nakahara T, Murakami K, Jinzaki M, Mimura M, Tabuchi H.

Psychogeriatrics. 2019 Jul;19(4):325-332. doi: 10.1111/psyg.12397. Epub 2019 Jan 27.

PMID:
30688000
47.

Focal 123I-MIBG Uptake in the Medial Segment of the Normal Liver.

Matsusaka Y, Nakahara T, Iwabuchi Y, Minami Y, Jinzaki M.

Clin Nucl Med. 2019 Mar;44(3):e170-e171. doi: 10.1097/RLU.0000000000002449.

PMID:
30672756
48.

Hmga2 regulation of tooth formation and association with Sox2 and Nanog expression.

Kodama Y, Harinath D, Mihara-Tomiyama N, Tominaga N, Ide Y, Nakahara T, Maeda M, Igarashi M, D'Armiento J, Chada K, Imai K.

Biochem Biophys Res Commun. 2019 Feb 19;509(4):1008-1014. doi: 10.1016/j.bbrc.2019.01.017. Epub 2019 Jan 14.

PMID:
30654938
49.

Correction: Reduction of hepatitis B surface antigen in sequential versus add-on pegylated interferon to nucleoside/nucleotide analogue therapy in HBe-antigen-negative chronic hepatitis B patients: a pilot study.

Tatsukawa Y, Tsuge M, Kawakami Y, Hiyama Y, Murakami E, Kurihara M, Nomura M, Tsushima K, Uchida T, Nakahara T, Miki D, Kawaoka T, Abe-Chayama H, Imamura M, Aikata H, Ochi H, Hayes CN, Kawakami H, Chayama K.

Antivir Ther. 2019;23(8):709. doi: 10.3851/IMP3289. No abstract available.

PMID:
30632982
50.

Cross-sectional multicenter observational study of psoriatic arthritis in Japanese patients: Relationship between skin and joint symptoms and results of treatment with tumor necrosis factor-α inhibitors.

Tsuruta N, Narisawa Y, Imafuku S, Ito K, Yamaguchi K, Miyagi T, Takahashi K, Fukamatsu H, Morizane S, Koketsu H, Yamaguchi M, Hino R, Nakamura M, Ohyama B, Ohata C, Kuwashiro M, Sato T, Saito K, Kaneko S, Yonekura K, Hayashi H, Yanase T, Morimoto K, Sugita K, Yanagihara S, Kikuchi S, Mitoma C, Nakahara T, Furue M, Okazaki F.

J Dermatol. 2019 Mar;46(3):193-198. doi: 10.1111/1346-8138.14745. Epub 2019 Jan 10.

PMID:
30628100

Supplemental Content

Loading ...
Support Center